ARCHIVES

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Science Policy: All’s Well In Access to Trials, GAO Study Finds; NIH Disagrees

November 5, 1999

Science Policy: Stem Cell Research Guidelines Formalize NIH Funding Polices

December 3, 1999

Centers Got $35 Million In NIH Construction $$; Send In Applications, Branch Chief Says

July 24, 1992

Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks

May 5, 1995

Give New Investigators “Special Consideration,” Advisors Tell NCI

June 28, 2002

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991